Skip to main content

Table 4 Linear Regression Line Slopes by Cannabinoid Ordered by Slope of Cannabidiol Regression Line

From: Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003–2017: part 1 – continuous bivariate analysis

No

Cancer

THC Slope

Cannabidiol Slope

Cannabichromene Slope

Cannabinol Slope

Cannabigerol Slope

1

Prostate

-25.4999

15.0011

-13.9506

-30.0790

-19.2506

2

Ovary

-14.0584

13.1851

-7.3292

-14.4851

-10.2498

3

Bladder

1.7824

11.7295

6.4769

1.1324

4.2897

4

Colorectal

-26.7535

10.2176

-17.3209

-26.1712

-20.6437

5

All_Cancer

-8.4752

9.2868

-4.2320

-9.1614

-6.3380

6

Hodgkins

-2.4889

7.1408

0.6127

-3.0804

-1.1613

7

Lung

-7.9645

6.5177

-4.7560

-8.0742

-6.3507

8

Brain

-1.7981

5.7887

0.6371

-2.0640

-0.5697

9

NH_Lymphoma

-2.1409

5.7874

0.3796

-2.3523

-0.9701

10

Esophagus

-3.5846

5.5661

-1.1051

-3.6621

-2.2324

11

Stomach

-0.9189

3.6282

0.6205

-1.0002

-0.0239

12

Breast

6.9024

2.9740

7.8292

6.6043

7.8098

13

Kaposi

-3.8468

1.8329

-3.3135

-3.8992

-3.3551

14

CLL

-2.2840

-0.1408

-2.2461

-2.2960

-2.6415

15

Vulva.&.Vagina

1.9115

-2.2486

0.7538

1.7822

1.0338

16

ALL

2.7533

-2.6301

1.1321

2.8397

1.9626

17

Cervix

-9.4408

-2.7163

-10.6708

-8.5617

-10.1059

18

Melanoma

2.9323

-2.7495

1.6322

3.0804

2.3487

19

Penis

0.1269

-3.6579

-1.9384

0.1510

-0.8129

20

Testis

-0.1463

-4.2166

-2.0019

0.4269

-1.3235

21

Thyroid

16.5506

-6.2049

12.2596

16.4519

13.4125

22

Pancreas

10.0878

-7.1535

6.0706

10.3462

8.1530

23

Liver

16.7546

-7.4077

11.4863

17.1885

14.0257

24

CML

4.9482

-8.6931

1.2939

5.6310

2.8365

25

Oropharynx

5.7731

-8.9380

1.8175

6.2778

3.5506

26

AML

9.9660

-9.5158

5.5823

10.4116

7.0927

27

Kidney

4.2116

-12.5177

-0.9390

4.6814

1.4827

28

Myeloma

3.2281

-12.8529

-1.9390

4.1031

0.1689